FocalTherics Q3 Revenue Up 26% to $9.8M; Cash Jumps to $56.3M After $42.4M Raise
FOCL has more than doubled off its 52-week low of $1.82 on light trading volume (0.4× avg).
Summary
FocalTherics grew Q3 revenue 25.5% to $9.8M with gross margin up to 51.4%, while the operating loss widened to $7.8M. Cash stands at $56.3M after the August offering and EIB Tranche B draw, funding at least twelve months of operations.
Key Events · Earnings and Guidance · FOCL
-
Q3 Revenue Grows 25.5% to $9.8M
Total revenue rose to $9.8M from $7.8M a year earlier, with 7 Focal One units sold versus 6; nine-month revenue reached $34.6M, up 45.2% from $23.8M on 31 Focal One units versus 21.
-
Gross Margin Expands, Operating Loss Widens
Gross margin improved to 51.4% from 46.6% on lower Focal One standard cost and better fixed-cost absorption, but operating expenses rose to $12.8M from $10.3M, pushing the operating loss to $7.8M from $6.7M.
-
Net Loss Flattered by Non-Cash Warrant Gain
The $4.5M net loss (-$0.10 per share) versus $5.9M (-$0.16) includes a $2.6M favorable non-cash change in fair value of the EIB warrants — a mark-to-market entry, not cash and not new dilution. The nine-month net loss widened to $28.0M from $19.8M on a $6.0M non-cash warrant and loan amortization charge.
-
Cash Reaches $56.3M After Capital Raise
Cash and equivalents were $56.3M at September 30, 2026, up $35.8M from December 31, 2025, reflecting roughly $43.1M of net offering proceeds and $14.0M from the EIB Tranche B draw; management states this funds at least twelve months of operations.
Analysis · FOCL · Industrial Applications And Services
The top line is real and margin-accretive: Q3 sales rose 25.5% to $9.8M and gross margin expanded to 51.4% from 46.6%. Yet the operating loss still widened to $7.8M from $6.7M as selling and marketing spend climbed. A $4.5M net loss looks better than last year's $5.9M only because of a $2.6M non-cash gain on remeasuring the EIB warrants — a mark-to-market entry tied to the share price, not cash and not new dilution. The balance sheet is the real story: $56.3M of cash after the August ADS offering and the Tranche B draw gives management at least twelve months of runway by its own statement, removing near-term financing risk while the HIFU business scales.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FOCL was trading at $4.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $162.7M. The 52-week trading range was $1.82 to $6.40. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.